In addition it addresses the FDA’s communications Along with the applicant, the retention of information that support the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may well transfer possession of the SE report to a new applicant and electronic submission with the SE report an